advisorsecurities master

AZTRAzitra Inc

CSNYSE American, LLC (XASE)·USD

Identity

Security key
12175
Ticker
AZTR
Type
CSCommon Stock
Exchange
NYSE American, LLC(XASE)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
2023-06-16
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
AZTR

Detail

Enriched 2026-08-14 20:47

Market cap
$2,185,979.13
Shares outstanding (class)
16,192,438
Shares outstanding (weighted)
16,192,438
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
13
Location
BRANFORD, CT
Description

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data